191 related articles for article (PubMed ID: 22574885)
1. Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda.
Meredith SE; Cross C; Amazigo UV
Health Res Policy Syst; 2012 May; 10():16. PubMed ID: 22574885
[TBL] [Abstract][Full Text] [Related]
2. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.
Homeida M; Braide E; Elhassan E; Amazigo UV; Liese B; Benton B; Noma M; Etya'alé D; Dadzie KY; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S93-104. PubMed ID: 12081254
[TBL] [Abstract][Full Text] [Related]
3. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC).
Amazigo UV; Brieger WR; Katabarwa M; Akogun O; Ntep M; Boatin B; N'Doyo J; Noma M; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S41-58. PubMed ID: 12081250
[TBL] [Abstract][Full Text] [Related]
4. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC).
Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252
[TBL] [Abstract][Full Text] [Related]
5. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC).
Sékétéli A; Adeoye G; Eyamba A; Nnoruka E; Drameh P; Amazigo UV; Noma M; Agboton F; Aholou Y; Kale OO; Dadzie KY
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S15-28. PubMed ID: 12081247
[TBL] [Abstract][Full Text] [Related]
6. River blindness: a success story under threat?
Basáñez MG; Pion SD; Churcher TS; Breitling LP; Little MP; Boussinesq M
PLoS Med; 2006 Sep; 3(9):e371. PubMed ID: 17002504
[TBL] [Abstract][Full Text] [Related]
7. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda.
Sama MT; Homeida M; Ngang P; Liese BH; Amazigo U; Seketeli A
Trop Doct; 2003 Oct; 33(4):237-41. PubMed ID: 14620432
[TBL] [Abstract][Full Text] [Related]
8. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).
Amazigo UV; Obono M; Dadzie KY; Remme J; Jiya J; Ndyomugyenyi R; Roungou JB; Noma M; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S75-92. PubMed ID: 12081253
[TBL] [Abstract][Full Text] [Related]
9. Ten years of NGDO action against river blindness.
Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
[TBL] [Abstract][Full Text] [Related]
10. The World Bank.
Bangoura O
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152
[TBL] [Abstract][Full Text] [Related]
11. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin and onchocerciasis: is it all solved?
Hopkins AD
Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585
[TBL] [Abstract][Full Text] [Related]
14. Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.
Katabarwa MN; Habomugisha P; Agunyo S; McKelvey AC; Ogweng N; Kwebiiha S; Byenume F; Male B; McFarland D
Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):265-72. PubMed ID: 20106493
[TBL] [Abstract][Full Text] [Related]
15. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
16. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
17. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
[TBL] [Abstract][Full Text] [Related]
18. Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.
Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Ghogomu SM; Godin I
Parasit Vectors; 2019 May; 12(1):246. PubMed ID: 31109348
[TBL] [Abstract][Full Text] [Related]
19. Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.
Bush S; Hopkins AD
Acta Trop; 2011 Sep; 120 Suppl 1():S169-72. PubMed ID: 21470555
[TBL] [Abstract][Full Text] [Related]
20. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Etya'alé DE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
